Centi B9
Alternative Names: Centi-B9Latest Information Update: 25 Jun 2021
At a glance
- Originator Centivax
- Class Antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Coronavirus infections
Most Recent Events
- 08 Jun 2021 Preclinical trials in Coronavirus infections in USA (Parenteral)